Thomas Wilder Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Wilder.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Wilder. Thomas Wilder is Director in ENDOLOGIX INC /DE/ ($ELGX) and Director in Penumbra Inc ($PEN).
Latest Insider Trading Transactions of Thomas Wilder
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | PEN | Penumbra Inc | Wilder Thomas | Director | Grant | A | 0.00 | 535 | 0 | 535 | 0 to 535 |
Jan 06 2021 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 174.32 | 115 | 20,047 | 148 | 263 to 148 (-43.73 %) |
Oct 05 2020 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 196.06 | 115 | 22,547 | 263 | 378 to 263 (-30.42 %) |
Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 0.08 | 12,088 | 1,009 | 0 | 12.1 K to 0 (-100.00 %) |
Aug 14 2020 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 0.08 | 15,776 | 1,262 | 12,088 | 27.9 K to 12.1 K (-56.62 %) |
Jul 15 2020 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 192.47 | 230 | 44,268 | 526 | 756 to 526 (-30.42 %) |
Jul 15 2020 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 192.47 | 230 | 44,268 | 526 | 756 to 526 (-30.42 %) |
Feb 13 2020 | PEN | Penumbra Inc | Wilder Thomas | Director | Grant | A | 0.00 | 756 | 0 | 756 | 0 to 756 |
Jan 03 2020 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 164.16 | 118 | 19,371 | 238 | 356 to 238 (-33.15 %) |
Oct 03 2019 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 134.93 | 118 | 15,922 | 356 | 474 to 356 (-24.89 %) |
Aug 15 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 6.61 | 1,369 | 9,049 | 27,864 | 29.2 K to 27.9 K (-4.68 %) |
Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | A | 6.67 | 9,023 | 60,183 | 9,023 | |
Aug 06 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 13,494 | 0 | 29,233 | 15.7 K to 29.2 K (+85.74 %) |
Jul 17 2019 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 169.92 | 237 | 40,271 | 3,733 | 4 K to 3.7 K (-5.97 %) |
May 09 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 6.34 | 1,455 | 9,224 | 15,739 | 17.2 K to 15.7 K (-8.46 %) |
Feb 12 2019 | PEN | Penumbra Inc | Wilder Thomas | Director | Grant | A | 0.00 | 949 | 0 | 3,970 | 3 K to 4 K (+31.41 %) |
Jan 04 2019 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 120.59 | 152 | 18,330 | 3,021 | 3.2 K to 3 K (-4.79 %) |
Jan 02 2019 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 120,887 | 0 | 171,947 | 51.1 K to 171.9 K (+236.75 %) |
Oct 04 2018 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 146.96 | 151 | 22,191 | 3,173 | 3.3 K to 3.2 K (-4.54 %) |
Jul 13 2018 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 138.50 | 304 | 42,104 | 3,324 | 3.6 K to 3.3 K (-8.38 %) |
Feb 21 2018 | PEN | Penumbra Inc | Wilder Thomas | Director | Grant | A | 0.00 | 1,215 | 0 | 3,628 | 2.4 K to 3.6 K (+50.35 %) |
Jan 04 2018 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 92.05 | 200 | 18,410 | 2,413 | 2.6 K to 2.4 K (-7.65 %) |
Jan 04 2018 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 89.90 | 145 | 13,036 | 2,613 | 2.8 K to 2.6 K (-5.26 %) |
Oct 04 2017 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 90.20 | 345 | 31,119 | 2,758 | 3.1 K to 2.8 K (-11.12 %) |
Jul 20 2017 | PEN | Penumbra Inc | Wilder Thomas | Director | Sell | S | 86.10 | 345 | 29,705 | 3,103 | 3.4 K to 3.1 K (-10.01 %) |
Jun 02 2017 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 22,822 | 0 | 51,060 | 28.2 K to 51.1 K (+80.82 %) |
Apr 19 2017 | PEN | Penumbra Inc | Wilder Thomas | Director | Grant | A | 0.00 | 1,448 | 0 | 3,448 | 2 K to 3.4 K (+72.40 %) |
Jan 13 2017 | PEN | Penumbra Inc | Wilder Thomas | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Jun 03 2016 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 7,657 | 0 | 28,238 | 20.6 K to 28.2 K (+37.20 %) |
Jun 01 2015 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 6,028 | 0 | 20,581 | 14.6 K to 20.6 K (+41.42 %) |
May 27 2015 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 16.08 | 3,790 | 60,943 | 14,553 | 18.3 K to 14.6 K (-20.66 %) |
Aug 05 2014 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 13.68 | 3,500 | 47,880 | 18,343 | 21.8 K to 18.3 K (-16.02 %) |
May 27 2014 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 7,593 | 0 | 21,843 | 14.3 K to 21.8 K (+53.28 %) |
Jun 03 2013 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | M | 8.26 | 10,000 | 82,600 | 0 | |
Jun 03 2013 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | M | 4.36 | 12,500 | 54,500 | 0 | |
Jun 03 2013 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 13.25 | 22,500 | 298,125 | 14,250 | 36.8 K to 14.3 K (-61.22 %) |
Jun 03 2013 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Buy | M | 8.26 | 10,000 | 82,600 | 36,750 | 26.8 K to 36.8 K (+37.38 %) |
Jun 03 2013 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Buy | M | 4.36 | 12,500 | 54,500 | 26,750 | 14.3 K to 26.8 K (+87.72 %) |
May 28 2013 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 0.00 | 7,148 | 0 | 14,250 | 7.1 K to 14.3 K (+100.65 %) |
Nov 01 2012 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | M | 8.26 | 10,000 | 82,600 | 10,000 | |
Nov 01 2012 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 13.56 | 10,000 | 135,600 | 7,102 | 17.1 K to 7.1 K (-58.47 %) |
Nov 01 2012 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Buy | M | 8.26 | 10,000 | 82,600 | 17,102 | 7.1 K to 17.1 K (+140.81 %) |
Sep 04 2012 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | M | 4.36 | 12,500 | 54,500 | 25,000 | |
Sep 04 2012 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 12.02 | 12,500 | 150,250 | 7,102 | 19.6 K to 7.1 K (-63.77 %) |
Sep 04 2012 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Buy | M | 4.36 | 12,500 | 54,500 | 19,602 | 7.1 K to 19.6 K (+176.01 %) |
May 25 2012 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Grant | A | 14.08 | 7,102 | 99,996 | 7,102 | 0 to 7.1 K |
Dec 07 2011 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | M | 4.36 | 12,500 | 54,500 | 37,500 | |
Dec 07 2011 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Sell | S | 11.49 | 12,500 | 143,625 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 07 2011 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Buy | M | 4.36 | 12,500 | 54,500 | 12,500 | 0 to 12.5 K |
May 27 2011 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | A | 8.26 | 20,000 | 165,200 | 20,000 | |
May 24 2010 | ELGX | ENDOLOGIX INC /DE/ | Wilder Thomas | Director | Option Exercise | A | 4.36 | 50,000 | 218,000 | 50,000 |
Page: 1